Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pro-Test Diagnostics is a Swedish biotechnology company specializing in the development of advanced molecular diagnostic tools for the sports industry. The company's primary focus is on detecting autologous blood transfusion (blood doping), a practice that has historically been difficult to identify using traditional testing methods. By utilizing gene expression profiling and RNA-based biomarkers, Pro-Test Diagnostics provides anti-doping agencies with high-sensitivity assays to ensure fair play in professional athletics. Their technology platform aims to supplement the Athlete Biological Passport with more direct evidence of blood manipulation by measuring specific gene expression changes associated with the reintroduction of stored blood.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pro-Test.